nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—ALB—Estropipate—osteoporosis	0.187	0.253	CbGbCtD
Ivacaftor—ALB—Estradiol—osteoporosis	0.0775	0.105	CbGbCtD
Ivacaftor—ABCB1—Ethinyl Estradiol—osteoporosis	0.0629	0.0854	CbGbCtD
Ivacaftor—CYP3A4—Estropipate—osteoporosis	0.0585	0.0794	CbGbCtD
Ivacaftor—CYP3A4—Calcitriol—osteoporosis	0.0585	0.0794	CbGbCtD
Ivacaftor—CYP3A4—Ergocalciferol—osteoporosis	0.0468	0.0635	CbGbCtD
Ivacaftor—ABCB1—Conjugated Estrogens—osteoporosis	0.0462	0.0627	CbGbCtD
Ivacaftor—ABCB1—Estradiol—osteoporosis	0.0405	0.0551	CbGbCtD
Ivacaftor—CYP3A4—Raloxifene—osteoporosis	0.039	0.053	CbGbCtD
Ivacaftor—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0377	0.0512	CbGbCtD
Ivacaftor—CYP3A4—Cholecalciferol—osteoporosis	0.0301	0.0409	CbGbCtD
Ivacaftor—CYP3A4—Conjugated Estrogens—osteoporosis	0.0277	0.0376	CbGbCtD
Ivacaftor—CYP3A4—Estradiol—osteoporosis	0.0243	0.033	CbGbCtD
Ivacaftor—Breast mass—Ethinyl Estradiol—osteoporosis	0.019	0.0723	CcSEcCtD
Ivacaftor—Nipple pain—Estradiol—osteoporosis	0.0136	0.0518	CcSEcCtD
Ivacaftor—Breast mass—Estradiol—osteoporosis	0.0124	0.0472	CcSEcCtD
Ivacaftor—Musculoskeletal chest pain—Zoledronate—osteoporosis	0.00477	0.0182	CcSEcCtD
Ivacaftor—Sinus headache—Estradiol—osteoporosis	0.00438	0.0167	CcSEcCtD
Ivacaftor—Transaminases increased—Alendronate—osteoporosis	0.00437	0.0166	CcSEcCtD
Ivacaftor—Sinus congestion—Estradiol—osteoporosis	0.00287	0.0109	CcSEcCtD
Ivacaftor—Oropharyngeal pain—Ibandronate—osteoporosis	0.00284	0.0108	CcSEcCtD
Ivacaftor—Hyperaesthesia—Zoledronate—osteoporosis	0.00236	0.00899	CcSEcCtD
Ivacaftor—Oropharyngeal pain—Zoledronate—osteoporosis	0.00204	0.00776	CcSEcCtD
Ivacaftor—Hyperaesthesia—Estradiol—osteoporosis	0.00182	0.00693	CcSEcCtD
Ivacaftor—Breast disorder—Estropipate—osteoporosis	0.00177	0.00674	CcSEcCtD
Ivacaftor—Breast disorder—Raloxifene—osteoporosis	0.00171	0.00653	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Raloxifene—osteoporosis	0.00171	0.00651	CcSEcCtD
Ivacaftor—Breast disorder—Ibandronate—osteoporosis	0.0017	0.00647	CcSEcCtD
Ivacaftor—Nasopharyngitis—Ibandronate—osteoporosis	0.00168	0.0064	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Calcitriol—osteoporosis	0.00166	0.00631	CcSEcCtD
Ivacaftor—Nasopharyngitis—Calcitriol—osteoporosis	0.00164	0.00627	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Estropipate—osteoporosis	0.00157	0.006	CcSEcCtD
Ivacaftor—Infestation NOS—Estropipate—osteoporosis	0.00151	0.00575	CcSEcCtD
Ivacaftor—Infestation—Estropipate—osteoporosis	0.00151	0.00575	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Ibandronate—osteoporosis	0.00151	0.00575	CcSEcCtD
Ivacaftor—Infestation NOS—Ibandronate—osteoporosis	0.00145	0.00552	CcSEcCtD
Ivacaftor—Infestation—Ibandronate—osteoporosis	0.00145	0.00552	CcSEcCtD
Ivacaftor—Breast disorder—Ethinyl Estradiol—osteoporosis	0.00143	0.00547	CcSEcCtD
Ivacaftor—Breast disorder—Risedronate—osteoporosis	0.0014	0.00533	CcSEcCtD
Ivacaftor—Nasopharyngitis—Risedronate—osteoporosis	0.00138	0.00527	CcSEcCtD
Ivacaftor—Rhinitis—Estropipate—osteoporosis	0.00136	0.00518	CcSEcCtD
Ivacaftor—Rhinitis—Raloxifene—osteoporosis	0.00132	0.00501	CcSEcCtD
Ivacaftor—Nasopharyngitis—Pamidronate—osteoporosis	0.00132	0.00501	CcSEcCtD
Ivacaftor—Connective tissue disorder—Raloxifene—osteoporosis	0.00129	0.00491	CcSEcCtD
Ivacaftor—Connective tissue disorder—Ibandronate—osteoporosis	0.00128	0.00487	CcSEcCtD
Ivacaftor—Gynaecomastia—Estradiol—osteoporosis	0.00128	0.00486	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Ethinyl Estradiol—osteoporosis	0.00127	0.00486	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Risedronate—osteoporosis	0.00124	0.00474	CcSEcCtD
Ivacaftor—Infestation NOS—Ethinyl Estradiol—osteoporosis	0.00122	0.00466	CcSEcCtD
Ivacaftor—Infestation—Ethinyl Estradiol—osteoporosis	0.00122	0.00466	CcSEcCtD
Ivacaftor—Mediastinal disorder—Estropipate—osteoporosis	0.00122	0.00465	CcSEcCtD
Ivacaftor—Ear pain—Estradiol—osteoporosis	0.00121	0.00463	CcSEcCtD
Ivacaftor—Nasopharyngitis—Zoledronate—osteoporosis	0.0012	0.00458	CcSEcCtD
Ivacaftor—Infestation NOS—Risedronate—osteoporosis	0.00119	0.00455	CcSEcCtD
Ivacaftor—Infestation—Risedronate—osteoporosis	0.00119	0.00455	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Pamidronate—osteoporosis	0.00118	0.0045	CcSEcCtD
Ivacaftor—Mediastinal disorder—Ibandronate—osteoporosis	0.00117	0.00446	CcSEcCtD
Ivacaftor—Breast disorder—Conjugated Estrogens—osteoporosis	0.00117	0.00446	CcSEcCtD
Ivacaftor—Arthralgia—Etidronic acid—osteoporosis	0.00116	0.00442	CcSEcCtD
Ivacaftor—Diarrhoea—Calcium Acetate—osteoporosis	0.00116	0.00442	CcSEcCtD
Ivacaftor—Nasal congestion—Estradiol—osteoporosis	0.00114	0.00433	CcSEcCtD
Ivacaftor—Infestation—Pamidronate—osteoporosis	0.00113	0.00432	CcSEcCtD
Ivacaftor—Infestation NOS—Pamidronate—osteoporosis	0.00113	0.00432	CcSEcCtD
Ivacaftor—Dizziness—Calcium Acetate—osteoporosis	0.00112	0.00427	CcSEcCtD
Ivacaftor—Infection—Etidronic acid—osteoporosis	0.00111	0.00421	CcSEcCtD
Ivacaftor—Rhinitis—Ethinyl Estradiol—osteoporosis	0.0011	0.0042	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Zoledronate—osteoporosis	0.00108	0.00411	CcSEcCtD
Ivacaftor—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.00108	0.00411	CcSEcCtD
Ivacaftor—Rhinitis—Risedronate—osteoporosis	0.00107	0.00409	CcSEcCtD
Ivacaftor—Connective tissue disorder—Risedronate—osteoporosis	0.00105	0.00401	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.00104	0.00396	CcSEcCtD
Ivacaftor—Infestation NOS—Zoledronate—osteoporosis	0.00104	0.00395	CcSEcCtD
Ivacaftor—Infestation—Zoledronate—osteoporosis	0.00104	0.00395	CcSEcCtD
Ivacaftor—Rhinitis—Pamidronate—osteoporosis	0.00102	0.00389	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00101	0.00386	CcSEcCtD
Ivacaftor—Nausea—Calcium Acetate—osteoporosis	0.00101	0.00384	CcSEcCtD
Ivacaftor—Myalgia—Estropipate—osteoporosis	0.001	0.00383	CcSEcCtD
Ivacaftor—Arthralgia—Estropipate—osteoporosis	0.001	0.00383	CcSEcCtD
Ivacaftor—Connective tissue disorder—Pamidronate—osteoporosis	0.001	0.00381	CcSEcCtD
Ivacaftor—Tinnitus—Risedronate—osteoporosis	0.000998	0.0038	CcSEcCtD
Ivacaftor—Infestation—Conjugated Estrogens—osteoporosis	0.000997	0.0038	CcSEcCtD
Ivacaftor—Infestation NOS—Conjugated Estrogens—osteoporosis	0.000997	0.0038	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000997	0.0038	CcSEcCtD
Ivacaftor—Myalgia—Alendronate—osteoporosis	0.000989	0.00377	CcSEcCtD
Ivacaftor—Arthralgia—Raloxifene—osteoporosis	0.000973	0.00371	CcSEcCtD
Ivacaftor—Myalgia—Raloxifene—osteoporosis	0.000973	0.00371	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000966	0.00368	CcSEcCtD
Ivacaftor—Mediastinal disorder—Risedronate—osteoporosis	0.000965	0.00368	CcSEcCtD
Ivacaftor—Arthralgia—Ibandronate—osteoporosis	0.000963	0.00367	CcSEcCtD
Ivacaftor—Myalgia—Ibandronate—osteoporosis	0.000963	0.00367	CcSEcCtD
Ivacaftor—Infection—Estropipate—osteoporosis	0.000956	0.00364	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000956	0.00364	CcSEcCtD
Ivacaftor—Nervous system disorder—Estropipate—osteoporosis	0.000944	0.0036	CcSEcCtD
Ivacaftor—Myalgia—Calcitriol—osteoporosis	0.000942	0.00359	CcSEcCtD
Ivacaftor—Infection—Alendronate—osteoporosis	0.000942	0.00359	CcSEcCtD
Ivacaftor—Breast disorder—Estradiol—osteoporosis	0.000936	0.00357	CcSEcCtD
Ivacaftor—Skin disorder—Estropipate—osteoporosis	0.000935	0.00356	CcSEcCtD
Ivacaftor—Infection—Raloxifene—osteoporosis	0.000926	0.00353	CcSEcCtD
Ivacaftor—Nasopharyngitis—Estradiol—osteoporosis	0.000926	0.00353	CcSEcCtD
Ivacaftor—Mediastinal disorder—Pamidronate—osteoporosis	0.000917	0.0035	CcSEcCtD
Ivacaftor—Infection—Ibandronate—osteoporosis	0.000917	0.00349	CcSEcCtD
Ivacaftor—Nervous system disorder—Raloxifene—osteoporosis	0.000914	0.00348	CcSEcCtD
Ivacaftor—Connective tissue disorder—Zoledronate—osteoporosis	0.000914	0.00348	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00091	0.00347	CcSEcCtD
Ivacaftor—Skin disorder—Raloxifene—osteoporosis	0.000906	0.00345	CcSEcCtD
Ivacaftor—Nervous system disorder—Ibandronate—osteoporosis	0.000905	0.00345	CcSEcCtD
Ivacaftor—Rhinitis—Conjugated Estrogens—osteoporosis	0.000897	0.00342	CcSEcCtD
Ivacaftor—Skin disorder—Ibandronate—osteoporosis	0.000896	0.00342	CcSEcCtD
Ivacaftor—Nausea—Ergocalciferol—osteoporosis	0.000889	0.00339	CcSEcCtD
Ivacaftor—Abdominal pain—Etidronic acid—osteoporosis	0.000879	0.00335	CcSEcCtD
Ivacaftor—Skin disorder—Calcitriol—osteoporosis	0.000878	0.00334	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000877	0.00334	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000864	0.00329	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000849	0.00324	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000841	0.0032	CcSEcCtD
Ivacaftor—Mediastinal disorder—Zoledronate—osteoporosis	0.000838	0.00319	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Estradiol—osteoporosis	0.000832	0.00317	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Estropipate—osteoporosis	0.000831	0.00317	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000823	0.00314	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000808	0.00308	CcSEcCtD
Ivacaftor—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000807	0.00307	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000805	0.00307	CcSEcCtD
Ivacaftor—Infestation—Estradiol—osteoporosis	0.000798	0.00304	CcSEcCtD
Ivacaftor—Infestation NOS—Estradiol—osteoporosis	0.000798	0.00304	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000797	0.00304	CcSEcCtD
Ivacaftor—Arthralgia—Risedronate—osteoporosis	0.000793	0.00302	CcSEcCtD
Ivacaftor—Myalgia—Risedronate—osteoporosis	0.000793	0.00302	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000788	0.003	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Estropipate—osteoporosis	0.000787	0.003	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Alendronate—osteoporosis	0.000775	0.00295	CcSEcCtD
Ivacaftor—Infection—Ethinyl Estradiol—osteoporosis	0.000775	0.00295	CcSEcCtD
Ivacaftor—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000765	0.00292	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Raloxifene—osteoporosis	0.000762	0.00291	CcSEcCtD
Ivacaftor—Diarrhoea—Etidronic acid—osteoporosis	0.000761	0.0029	CcSEcCtD
Ivacaftor—Abdominal pain—Estropipate—osteoporosis	0.000761	0.0029	CcSEcCtD
Ivacaftor—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000758	0.00289	CcSEcCtD
Ivacaftor—Infection—Risedronate—osteoporosis	0.000756	0.00288	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Ibandronate—osteoporosis	0.000755	0.00288	CcSEcCtD
Ivacaftor—Myalgia—Pamidronate—osteoporosis	0.000754	0.00287	CcSEcCtD
Ivacaftor—Arthralgia—Pamidronate—osteoporosis	0.000754	0.00287	CcSEcCtD
Ivacaftor—Abdominal pain—Alendronate—osteoporosis	0.000749	0.00286	CcSEcCtD
Ivacaftor—Nervous system disorder—Risedronate—osteoporosis	0.000746	0.00284	CcSEcCtD
Ivacaftor—Skin disorder—Risedronate—osteoporosis	0.000739	0.00282	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Calcitriol—osteoporosis	0.000739	0.00282	CcSEcCtD
Ivacaftor—Abdominal pain—Raloxifene—osteoporosis	0.000737	0.00281	CcSEcCtD
Ivacaftor—Abdominal pain—Ibandronate—osteoporosis	0.00073	0.00278	CcSEcCtD
Ivacaftor—Infection—Pamidronate—osteoporosis	0.000718	0.00274	CcSEcCtD
Ivacaftor—Rhinitis—Estradiol—osteoporosis	0.000718	0.00274	CcSEcCtD
Ivacaftor—Abdominal pain—Calcitriol—osteoporosis	0.000714	0.00272	CcSEcCtD
Ivacaftor—Nervous system disorder—Pamidronate—osteoporosis	0.000709	0.0027	CcSEcCtD
Ivacaftor—Connective tissue disorder—Estradiol—osteoporosis	0.000704	0.00268	CcSEcCtD
Ivacaftor—Rash—Etidronic acid—osteoporosis	0.000701	0.00267	CcSEcCtD
Ivacaftor—Dermatitis—Etidronic acid—osteoporosis	0.000701	0.00267	CcSEcCtD
Ivacaftor—Headache—Etidronic acid—osteoporosis	0.000697	0.00266	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000693	0.00264	CcSEcCtD
Ivacaftor—Myalgia—Zoledronate—osteoporosis	0.000689	0.00263	CcSEcCtD
Ivacaftor—Arthralgia—Zoledronate—osteoporosis	0.000689	0.00263	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000684	0.00261	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000674	0.00257	CcSEcCtD
Ivacaftor—Tinnitus—Estradiol—osteoporosis	0.000668	0.00255	CcSEcCtD
Ivacaftor—Myalgia—Conjugated Estrogens—osteoporosis	0.000663	0.00253	CcSEcCtD
Ivacaftor—Arthralgia—Conjugated Estrogens—osteoporosis	0.000663	0.00253	CcSEcCtD
Ivacaftor—Nausea—Etidronic acid—osteoporosis	0.000661	0.00252	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000659	0.00251	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000659	0.00251	CcSEcCtD
Ivacaftor—Diarrhoea—Estropipate—osteoporosis	0.000659	0.00251	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Risedronate—osteoporosis	0.000657	0.0025	CcSEcCtD
Ivacaftor—Infection—Zoledronate—osteoporosis	0.000656	0.0025	CcSEcCtD
Ivacaftor—Diarrhoea—Alendronate—osteoporosis	0.000649	0.00247	CcSEcCtD
Ivacaftor—Nervous system disorder—Zoledronate—osteoporosis	0.000648	0.00247	CcSEcCtD
Ivacaftor—Mediastinal disorder—Estradiol—osteoporosis	0.000646	0.00246	CcSEcCtD
Ivacaftor—Skin disorder—Zoledronate—osteoporosis	0.000642	0.00245	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000638	0.00243	CcSEcCtD
Ivacaftor—Diarrhoea—Raloxifene—osteoporosis	0.000638	0.00243	CcSEcCtD
Ivacaftor—Dizziness—Estropipate—osteoporosis	0.000636	0.00243	CcSEcCtD
Ivacaftor—Infection—Conjugated Estrogens—osteoporosis	0.000632	0.00241	CcSEcCtD
Ivacaftor—Diarrhoea—Ibandronate—osteoporosis	0.000631	0.00241	CcSEcCtD
Ivacaftor—Dizziness—Alendronate—osteoporosis	0.000627	0.00239	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000624	0.00238	CcSEcCtD
Ivacaftor—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000624	0.00238	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Risedronate—osteoporosis	0.000622	0.00237	CcSEcCtD
Ivacaftor—Diarrhoea—Calcitriol—osteoporosis	0.000618	0.00236	CcSEcCtD
Ivacaftor—Skin disorder—Conjugated Estrogens—osteoporosis	0.000618	0.00235	CcSEcCtD
Ivacaftor—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000617	0.00235	CcSEcCtD
Ivacaftor—Dizziness—Raloxifene—osteoporosis	0.000616	0.00235	CcSEcCtD
Ivacaftor—Dizziness—Ibandronate—osteoporosis	0.00061	0.00233	CcSEcCtD
Ivacaftor—Rash—Estropipate—osteoporosis	0.000607	0.00231	CcSEcCtD
Ivacaftor—Dermatitis—Estropipate—osteoporosis	0.000606	0.00231	CcSEcCtD
Ivacaftor—Headache—Estropipate—osteoporosis	0.000603	0.0023	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000602	0.00229	CcSEcCtD
Ivacaftor—Abdominal pain—Risedronate—osteoporosis	0.000601	0.00229	CcSEcCtD
Ivacaftor—Rash—Alendronate—osteoporosis	0.000598	0.00228	CcSEcCtD
Ivacaftor—Dermatitis—Alendronate—osteoporosis	0.000597	0.00228	CcSEcCtD
Ivacaftor—Headache—Alendronate—osteoporosis	0.000594	0.00226	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Pamidronate—osteoporosis	0.000591	0.00225	CcSEcCtD
Ivacaftor—Rash—Raloxifene—osteoporosis	0.000588	0.00224	CcSEcCtD
Ivacaftor—Dermatitis—Raloxifene—osteoporosis	0.000587	0.00224	CcSEcCtD
Ivacaftor—Headache—Raloxifene—osteoporosis	0.000584	0.00223	CcSEcCtD
Ivacaftor—Rash—Ibandronate—osteoporosis	0.000582	0.00222	CcSEcCtD
Ivacaftor—Dermatitis—Ibandronate—osteoporosis	0.000581	0.00222	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000579	0.00221	CcSEcCtD
Ivacaftor—Headache—Ibandronate—osteoporosis	0.000578	0.0022	CcSEcCtD
Ivacaftor—Nausea—Estropipate—osteoporosis	0.000572	0.00218	CcSEcCtD
Ivacaftor—Abdominal pain—Pamidronate—osteoporosis	0.000572	0.00218	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00057	0.00217	CcSEcCtD
Ivacaftor—Rash—Calcitriol—osteoporosis	0.00057	0.00217	CcSEcCtD
Ivacaftor—Dermatitis—Calcitriol—osteoporosis	0.000569	0.00217	CcSEcCtD
Ivacaftor—Headache—Calcitriol—osteoporosis	0.000566	0.00216	CcSEcCtD
Ivacaftor—Nausea—Alendronate—osteoporosis	0.000563	0.00215	CcSEcCtD
Ivacaftor—Nausea—Raloxifene—osteoporosis	0.000554	0.00211	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000549	0.00209	CcSEcCtD
Ivacaftor—Nausea—Ibandronate—osteoporosis	0.000548	0.00209	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Zoledronate—osteoporosis	0.00054	0.00206	CcSEcCtD
Ivacaftor—Nausea—Calcitriol—osteoporosis	0.000537	0.00205	CcSEcCtD
Ivacaftor—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000534	0.00203	CcSEcCtD
Ivacaftor—Arthralgia—Estradiol—osteoporosis	0.000531	0.00202	CcSEcCtD
Ivacaftor—Myalgia—Estradiol—osteoporosis	0.000531	0.00202	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000527	0.00201	CcSEcCtD
Ivacaftor—Abdominal pain—Zoledronate—osteoporosis	0.000522	0.00199	CcSEcCtD
Ivacaftor—Diarrhoea—Risedronate—osteoporosis	0.00052	0.00198	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00052	0.00198	CcSEcCtD
Ivacaftor—Dizziness—Ethinyl Estradiol—osteoporosis	0.000516	0.00197	CcSEcCtD
Ivacaftor—Infection—Estradiol—osteoporosis	0.000506	0.00193	CcSEcCtD
Ivacaftor—Dizziness—Risedronate—osteoporosis	0.000503	0.00192	CcSEcCtD
Ivacaftor—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000503	0.00192	CcSEcCtD
Ivacaftor—Nervous system disorder—Estradiol—osteoporosis	0.000499	0.0019	CcSEcCtD
Ivacaftor—Diarrhoea—Pamidronate—osteoporosis	0.000495	0.00189	CcSEcCtD
Ivacaftor—Skin disorder—Estradiol—osteoporosis	0.000494	0.00188	CcSEcCtD
Ivacaftor—Rash—Ethinyl Estradiol—osteoporosis	0.000492	0.00187	CcSEcCtD
Ivacaftor—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000491	0.00187	CcSEcCtD
Ivacaftor—Headache—Ethinyl Estradiol—osteoporosis	0.000489	0.00186	CcSEcCtD
Ivacaftor—Rash—Risedronate—osteoporosis	0.00048	0.00183	CcSEcCtD
Ivacaftor—Dermatitis—Risedronate—osteoporosis	0.000479	0.00183	CcSEcCtD
Ivacaftor—Dizziness—Pamidronate—osteoporosis	0.000478	0.00182	CcSEcCtD
Ivacaftor—Headache—Risedronate—osteoporosis	0.000476	0.00182	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000464	0.00177	CcSEcCtD
Ivacaftor—Nausea—Ethinyl Estradiol—osteoporosis	0.000463	0.00177	CcSEcCtD
Ivacaftor—Rash—Pamidronate—osteoporosis	0.000456	0.00174	CcSEcCtD
Ivacaftor—Dermatitis—Pamidronate—osteoporosis	0.000455	0.00174	CcSEcCtD
Ivacaftor—Headache—Pamidronate—osteoporosis	0.000453	0.00173	CcSEcCtD
Ivacaftor—Diarrhoea—Zoledronate—osteoporosis	0.000452	0.00172	CcSEcCtD
Ivacaftor—Nausea—Risedronate—osteoporosis	0.000452	0.00172	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Estradiol—osteoporosis	0.000439	0.00167	CcSEcCtD
Ivacaftor—Dizziness—Zoledronate—osteoporosis	0.000437	0.00166	CcSEcCtD
Ivacaftor—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000435	0.00166	CcSEcCtD
Ivacaftor—Nausea—Pamidronate—osteoporosis	0.000429	0.00164	CcSEcCtD
Ivacaftor—Dizziness—Conjugated Estrogens—osteoporosis	0.000421	0.0016	CcSEcCtD
Ivacaftor—Rash—Zoledronate—osteoporosis	0.000416	0.00159	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Estradiol—osteoporosis	0.000416	0.00159	CcSEcCtD
Ivacaftor—Dermatitis—Zoledronate—osteoporosis	0.000416	0.00159	CcSEcCtD
Ivacaftor—Headache—Zoledronate—osteoporosis	0.000414	0.00158	CcSEcCtD
Ivacaftor—Abdominal pain—Estradiol—osteoporosis	0.000402	0.00153	CcSEcCtD
Ivacaftor—Rash—Conjugated Estrogens—osteoporosis	0.000401	0.00153	CcSEcCtD
Ivacaftor—Dermatitis—Conjugated Estrogens—osteoporosis	0.000401	0.00153	CcSEcCtD
Ivacaftor—Headache—Conjugated Estrogens—osteoporosis	0.000398	0.00152	CcSEcCtD
Ivacaftor—Nausea—Zoledronate—osteoporosis	0.000392	0.0015	CcSEcCtD
Ivacaftor—Nausea—Conjugated Estrogens—osteoporosis	0.000378	0.00144	CcSEcCtD
Ivacaftor—Diarrhoea—Estradiol—osteoporosis	0.000348	0.00133	CcSEcCtD
Ivacaftor—Dizziness—Estradiol—osteoporosis	0.000337	0.00128	CcSEcCtD
Ivacaftor—Rash—Estradiol—osteoporosis	0.000321	0.00122	CcSEcCtD
Ivacaftor—Dermatitis—Estradiol—osteoporosis	0.000321	0.00122	CcSEcCtD
Ivacaftor—Headache—Estradiol—osteoporosis	0.000319	0.00122	CcSEcCtD
Ivacaftor—Nausea—Estradiol—osteoporosis	0.000302	0.00115	CcSEcCtD
Ivacaftor—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000144	0.108	CbGpPWpGaD
Ivacaftor—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	8.86e-05	0.0664	CbGpPWpGaD
Ivacaftor—CFTR—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.75e-05	0.0281	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—WDR1—osteoporosis	3.29e-05	0.0247	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	3.14e-05	0.0235	CbGpPWpGaD
Ivacaftor—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	3.13e-05	0.0235	CbGpPWpGaD
Ivacaftor—ALB—Lipoprotein metabolism—P4HB—osteoporosis	3.08e-05	0.0231	CbGpPWpGaD
Ivacaftor—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	3.01e-05	0.0226	CbGpPWpGaD
Ivacaftor—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	2.94e-05	0.0221	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—CAP1—osteoporosis	2.6e-05	0.0195	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	2.53e-05	0.019	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	2.48e-05	0.0186	CbGpPWpGaD
Ivacaftor—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	2.36e-05	0.0177	CbGpPWpGaD
Ivacaftor—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	2.3e-05	0.0172	CbGpPWpGaD
Ivacaftor—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	2.05e-05	0.0154	CbGpPWpGaD
Ivacaftor—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	2.05e-05	0.0154	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—PLEK—osteoporosis	1.89e-05	0.0142	CbGpPWpGaD
Ivacaftor—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	1.81e-05	0.0136	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	1.8e-05	0.0135	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—TLN1—osteoporosis	1.63e-05	0.0122	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—VCL—osteoporosis	1.61e-05	0.0121	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	1.55e-05	0.0116	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	1.53e-05	0.0115	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	1.46e-05	0.011	CbGpPWpGaD
Ivacaftor—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	1.42e-05	0.0106	CbGpPWpGaD
Ivacaftor—CFTR—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.41e-05	0.0106	CbGpPWpGaD
Ivacaftor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.32e-05	0.00989	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—FGA—osteoporosis	1.22e-05	0.00914	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	1.16e-05	0.00871	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	1.16e-05	0.00866	CbGpPWpGaD
Ivacaftor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	1.12e-05	0.00843	CbGpPWpGaD
Ivacaftor—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	1.11e-05	0.00833	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—FGB—osteoporosis	1.11e-05	0.00832	CbGpPWpGaD
Ivacaftor—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	1.11e-05	0.00832	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	1.06e-05	0.00797	CbGpPWpGaD
Ivacaftor—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	1.06e-05	0.00794	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	1.06e-05	0.00792	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	9.36e-06	0.00702	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	9.18e-06	0.00688	CbGpPWpGaD
Ivacaftor—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	9.11e-06	0.00683	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—SOD2—osteoporosis	8.65e-06	0.00648	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	8.39e-06	0.00629	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—GPX1—osteoporosis	8.25e-06	0.00619	CbGpPWpGaD
Ivacaftor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	8.13e-06	0.00609	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—MTHFR—osteoporosis	7.62e-06	0.00571	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—WDR1—osteoporosis	7.53e-06	0.00565	CbGpPWpGaD
Ivacaftor—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	7.3e-06	0.00547	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	7.23e-06	0.00542	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	7.14e-06	0.00535	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	6.87e-06	0.00515	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	6.56e-06	0.00491	CbGpPWpGaD
Ivacaftor—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	6.21e-06	0.00466	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	6.05e-06	0.00454	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	5.99e-06	0.00449	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	5.96e-06	0.00447	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CAP1—osteoporosis	5.95e-06	0.00446	CbGpPWpGaD
Ivacaftor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.9e-06	0.00443	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	5.87e-06	0.0044	CbGpPWpGaD
Ivacaftor—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.83e-06	0.00437	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.68e-06	0.00426	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	5.56e-06	0.00416	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	5.41e-06	0.00405	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—IGF1—osteoporosis	5.02e-06	0.00377	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	4.92e-06	0.00369	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.84e-06	0.00363	CbGpPWpGaD
Ivacaftor—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.79e-06	0.00359	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	4.79e-06	0.00359	CbGpPWpGaD
Ivacaftor—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.77e-06	0.00358	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—MGLL—osteoporosis	4.73e-06	0.00355	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—IL1B—osteoporosis	4.52e-06	0.00339	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.42e-06	0.00331	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—ANXA2—osteoporosis	4.33e-06	0.00324	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PLEK—osteoporosis	4.33e-06	0.00324	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.31e-06	0.00323	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	4.18e-06	0.00313	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	4.03e-06	0.00302	CbGpPWpGaD
Ivacaftor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	3.91e-06	0.00293	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.75e-06	0.00281	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TLN1—osteoporosis	3.73e-06	0.0028	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—VCL—osteoporosis	3.68e-06	0.00276	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	3.59e-06	0.00269	CbGpPWpGaD
Ivacaftor—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.55e-06	0.00266	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.44e-06	0.00258	CbGpPWpGaD
Ivacaftor—ABCB1—Allograft Rejection—IL1B—osteoporosis	3.43e-06	0.00257	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.28e-06	0.00246	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—TNF—osteoporosis	3.28e-06	0.00246	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	3.25e-06	0.00244	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—RAP1A—osteoporosis	3.07e-06	0.0023	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—TGFB1—osteoporosis	3.01e-06	0.00226	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.93e-06	0.00219	CbGpPWpGaD
Ivacaftor—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.88e-06	0.00216	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	2.87e-06	0.00215	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—FGA—osteoporosis	2.79e-06	0.00209	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PKM—osteoporosis	2.67e-06	0.002	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—FDPS—osteoporosis	2.67e-06	0.002	CbGpPWpGaD
Ivacaftor—ABCB1—Allograft Rejection—TGFB1—osteoporosis	2.67e-06	0.002	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—IL6—osteoporosis	2.65e-06	0.00198	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—TNF—osteoporosis	2.61e-06	0.00195	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.54e-06	0.00191	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—FGB—osteoporosis	2.54e-06	0.0019	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	2.53e-06	0.0019	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GPD2—osteoporosis	2.53e-06	0.0019	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PGLS—osteoporosis	2.53e-06	0.0019	CbGpPWpGaD
Ivacaftor—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.51e-06	0.00188	CbGpPWpGaD
Ivacaftor—ABCB1—Allograft Rejection—TNF—osteoporosis	2.49e-06	0.00187	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PKM—osteoporosis	2.34e-06	0.00175	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—FDPS—osteoporosis	2.34e-06	0.00175	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ATIC—osteoporosis	2.31e-06	0.00174	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PNP—osteoporosis	2.31e-06	0.00174	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.23e-06	0.00167	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PGLS—osteoporosis	2.22e-06	0.00166	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GPD2—osteoporosis	2.22e-06	0.00166	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.19e-06	0.00164	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.1e-06	0.00158	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PNP—osteoporosis	2.03e-06	0.00152	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ATIC—osteoporosis	2.03e-06	0.00152	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—OXCT1—osteoporosis	1.97e-06	0.00148	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CA2—osteoporosis	1.97e-06	0.00148	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MGLL—osteoporosis	1.92e-06	0.00144	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.81e-06	0.00136	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—OXCT1—osteoporosis	1.72e-06	0.00129	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CA2—osteoporosis	1.72e-06	0.00129	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MGLL—osteoporosis	1.68e-06	0.00126	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—IDH2—osteoporosis	1.63e-06	0.00122	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP27A1—osteoporosis	1.53e-06	0.00115	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—POMC—osteoporosis	1.53e-06	0.00115	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ACP5—osteoporosis	1.49e-06	0.00112	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.47e-06	0.0011	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—FDPS—osteoporosis	1.44e-06	0.00108	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PKM—osteoporosis	1.44e-06	0.00108	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—IDH2—osteoporosis	1.43e-06	0.00107	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.41e-06	0.00105	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—TPI1—osteoporosis	1.39e-06	0.00104	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PGLS—osteoporosis	1.37e-06	0.00102	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GPD2—osteoporosis	1.37e-06	0.00102	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP27A1—osteoporosis	1.34e-06	0.00101	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.34e-06	0.001	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.32e-06	0.000988	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.32e-06	0.000986	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ACP5—osteoporosis	1.31e-06	0.00098	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—P4HB—osteoporosis	1.3e-06	0.000977	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GAPDH—osteoporosis	1.28e-06	0.000959	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PNP—osteoporosis	1.25e-06	0.000937	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ATIC—osteoporosis	1.25e-06	0.000937	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—RAP1A—osteoporosis	1.25e-06	0.000934	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.23e-06	0.000923	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.23e-06	0.000921	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—TPI1—osteoporosis	1.22e-06	0.000911	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IGF1—osteoporosis	1.15e-06	0.000861	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—P4HB—osteoporosis	1.14e-06	0.000856	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GAPDH—osteoporosis	1.12e-06	0.000841	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—RAP1A—osteoporosis	1.09e-06	0.000819	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.09e-06	0.000815	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CA2—osteoporosis	1.06e-06	0.000796	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—OXCT1—osteoporosis	1.06e-06	0.000796	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MGLL—osteoporosis	1.04e-06	0.000776	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ENO1—osteoporosis	1.01e-06	0.000755	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PSMA2—osteoporosis	9.93e-07	0.000744	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PSMA5—osteoporosis	9.93e-07	0.000744	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ENO1—osteoporosis	8.83e-07	0.000662	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—IDH2—osteoporosis	8.8e-07	0.00066	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PSMA2—osteoporosis	8.7e-07	0.000652	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PSMA5—osteoporosis	8.7e-07	0.000652	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP27A1—osteoporosis	8.28e-07	0.000621	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP19A1—osteoporosis	8.05e-07	0.000604	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ACP5—osteoporosis	8.05e-07	0.000604	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—TPI1—osteoporosis	7.49e-07	0.000561	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP19A1—osteoporosis	7.06e-07	0.000529	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—P4HB—osteoporosis	7.04e-07	0.000528	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GAPDH—osteoporosis	6.91e-07	0.000518	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TGFB1—osteoporosis	6.88e-07	0.000516	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—RAP1A—osteoporosis	6.73e-07	0.000504	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ADCY5—osteoporosis	6.58e-07	0.000493	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GPX1—osteoporosis	6.56e-07	0.000492	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MTHFR—osteoporosis	6.05e-07	0.000454	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ADCY5—osteoporosis	5.77e-07	0.000432	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GPX1—osteoporosis	5.75e-07	0.000431	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ENO1—osteoporosis	5.44e-07	0.000408	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PSMA5—osteoporosis	5.36e-07	0.000402	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PSMA2—osteoporosis	5.36e-07	0.000402	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MTHFR—osteoporosis	5.3e-07	0.000398	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—POMC—osteoporosis	4.84e-07	0.000363	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.35e-07	0.000326	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—POMC—osteoporosis	4.24e-07	0.000318	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ADCY5—osteoporosis	3.55e-07	0.000266	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GPX1—osteoporosis	3.54e-07	0.000265	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTHFR—osteoporosis	3.27e-07	0.000245	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—POMC—osteoporosis	2.61e-07	0.000196	CbGpPWpGaD
